Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)

Keyphrases

• Epidermolysis Bullosa 100%
• Clinical Outcomes 100%
• Construct Validity 17%
• Intraclass Correlation Coefficient 17%
• Cronbach's alpha 11%
• Interobserver 11%
• Birmingham 11%
• Interobserver Reliability 11%
• Testretest Reliability 11%
• Validity/reliability 11%
• Clinical Trials 5%
• Patient-Reported Outcomes Measurement Information System (PROMIS) 5%
• Quality of Life Evaluation 5%
• Severe Disease 5%
• Disease Severity 5%
• Mild Disease 5%
• Between-subject 5%
• Clinical Score 5%
• Severity Assessment 5%
• Clinician Rating 5%
• Global Severity 5%
• Moderate Disease 5%
• Clinician-reported Outcomes 5%
• Blistering Disorder 5%
• Robust Reliability 5%
• Academic Hospital 5%
• Responsiveness to Change 5%
• Patient Quality of Life 5%
• Children's Dermatology Life Quality Index (CDLQI) 5%

Nursing and Health Professions

• Clinical Outcome 100%
• Epidermolysis bullosa 100%
• Correlation Coefficient 18%
• Construct Validity 18%
• Cronbach Alpha Coefficient 12%
• Patient-Reported Outcome 6%
• Epidermolysis Bullosa Dystrophica 6%
• Disease Severity 6%
• Dermatology Life Quality Index 6%
• Diseases 6%
• Quality of Life 6%
• Clinical Trial 6%

Medicine and Dentistry

• Epidermolysis bullosa 100%
• Clinician 18%
• Clinical Trial 6%
• Quality of Life 6%
• Observational Study 6%
• Epidermolysis Bullosa Dystrophica 6%
• Disease Severity 6%
• Dermatology Life Quality Index 6%
• Diseases 6%
• Patient-Reported Outcome 6%
• Genetics 6%